Driving performance under the influence of drugs: rationale for, and application of, a new test.
about
Sensitivity and validity of psychometric tests for assessing driving impairment: effects of sleep deprivationAlcohol calibration of tests measuring skills related to car driving.Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotypeResidual effects of zopiclone 7.5 mg on highway driving performance in insomnia patients and healthy controls: a placebo controlled crossover study.On-the-road driving performance and driving-related skills in older untreated insomnia patients and chronic users of hypnotics.Sedation, cognition, and antihistamines.Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjectsDrivers can poorly predict their own driving impairment: a comparison between measurements of subjective and objective driving quality.MDMA (ecstasy) effects on actual driving performance before and after sleep deprivation, as function of dose and concentration in blood and oral fluidOn-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy VolunteersOn-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly.On-the-road driving performance after use of the antihistamines mequitazine and l-mequitazine, alone and with alcohol.Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.A pooled analysis of on-the-road highway driving studies in actual traffic measuring standard deviation of lateral position (i.e., "weaving") while driving at a blood alcohol concentration of 0.5 g/L.Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence.Standard operation procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP)The use of kinetic-dynamic interactions in the evaluation of drugs.Gender differences in highway driving performance after administration of sleep medication: a review of the literature.Effects of central nervous system drugs on driving: speed variability versus standard deviation of lateral position as outcome measure of the on-the-road driving test.Meta-analysis of on-the-road experimental studies of hypnotics: effects of time after intake, dose, and half-life.Lapses of attention as outcome measure of the on-the-road driving test.Driving on ice: impaired driving skills in current methamphetamine users.The effects of acute treatment with paroxetine, amitriptyline, and placebo on driving performance and cognitive function in healthy Japanese subjects: a double-blind crossover trial.Driving functions in a video simulator in chronic non-malignant pain patients using and not using codeine.The clinical safety of H1-receptor antagonists. An EAACI position paper.Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance.The effects of acute treatment with tandospirone, diazepam, and placebo on driving performance and cognitive function in healthy volunteers.Effect of chronic opioid therapy on actual driving performance in non-cancer pain patients.Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem.Plasma amitriptyline level after acute administration, and driving performance in healthy volunteers.Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: a randomized crossover trial.Development of a portable psychometric testing device for use in the field: an alcohol investigation.The effects of acute treatment with ramelteon, triazolam, and placebo on driving performance, cognitive function, and equilibrium function in healthy volunteers.Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg.Driving impairment in depressed patients receiving long-term antidepressant treatment.Subjective sleepiness, simulated driving performance and blink duration: examining individual differences.Medicinal Δ(9) -tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests.MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function.Repeated dose effects of lormetazepam and flurazepam upon driving performance.Allergic rhinitis is a risk factor for traffic safety.
P2860
Q28543372-121C40F0-5557-436A-8EFB-DF16ECAFB96AQ33691882-83921393-980F-41EC-B20D-7B0FC619A845Q33796782-6FD36B8D-4F9F-4BF4-BD1D-3AFCC7683BCBQ33810623-1D00C841-6210-4712-ACCF-F834BC3FDF62Q33810643-C4C98EF2-34DA-4770-8870-44BB63902017Q34579815-39E579A9-5509-465B-85C5-AFEF01A0E902Q35214361-702F74E4-F073-40BC-B553-59CE041DC61CQ35675690-021571F0-90FB-46F5-A7EE-5D09A6649242Q36091083-4E0AECEE-1DF1-4E4C-912C-8BA63DA641A1Q36744112-A2E5E838-637C-4CE6-87FF-D55E4DD4927FQ37184429-5359EF49-E1EA-482F-AACE-5260B28BF014Q37184487-FCEB3FC2-BAA7-4A18-A78D-DF72CAA58AADQ37576289-03FE1999-7F84-425B-A9A3-B628C8C84CF9Q37639886-6C0D9932-4D1F-41E8-B2CE-B6D678D7D5E4Q37830027-B584795D-4462-455E-A93D-A083DB88A7BAQ37882415-36547D5C-3D73-4AEE-AD0D-186007634D53Q37911447-CAF0E068-952F-4977-BB5E-9682AE5BD588Q38011236-CDE14AFF-9283-4B5D-BE56-571C01A0680AQ38174544-F557E78B-661A-4725-B403-25514DB97CF4Q38200102-6CD7A093-D2E5-4E7E-8EFD-5778CC64AC58Q39361805-FCB13786-8046-4F4A-86EF-A492505127F7Q39578181-B8265787-BC13-4E85-835F-1AF3E2DAB139Q39841701-EBA7A3EF-6912-4AB4-97C1-1CB3C4C31F7BQ39954865-55643B01-7417-4BA6-A561-DEFE5BC44FB9Q41199457-F059C036-C75D-4E60-A99E-546E6D397B8AQ42080196-846CA53B-D853-4488-9ABA-1B7CF043A9DAQ43107435-A4553524-DD64-434C-85E7-92CF686C707DQ44343268-3A7A3C99-5BCB-4935-A2A0-44ED1B5740C1Q45954747-A2B2E995-3B43-480B-B882-9E38053CFFC8Q46298114-532EF501-0D1B-4A33-A2B7-A68F7C0186B3Q46727017-97C1372F-6459-43BC-953D-D898C0DDE561Q46871781-6946B741-0F6D-479E-8B01-4B8694779994Q48006027-1E4776C0-3CCA-4DC5-8F41-CAC3AE635B35Q48312001-F4A83487-40BD-403F-93EE-B48479A6380EQ48463458-C913CCD4-810A-4D59-BBD7-9EBE7165FECAQ48512351-A59D40A3-DADA-4ADB-92C6-5D67F6DF734EQ48789800-C833AA02-9C89-4A57-97FB-F6F13BA94733Q48930934-297D0B71-2E5F-4352-A529-09030258DD65Q48933149-091D02C7-B9FD-4B6E-B785-86B9B1879575Q50051731-3CBF9F4A-42DE-40EC-B4CE-FB7D65B9AFE2
P2860
Driving performance under the influence of drugs: rationale for, and application of, a new test.
description
1984 nî lūn-bûn
@nan
1984 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Driving performance under the ...... nd application of, a new test.
@ast
Driving performance under the ...... nd application of, a new test.
@en
Driving performance under the ...... nd application of, a new test.
@nl
type
label
Driving performance under the ...... nd application of, a new test.
@ast
Driving performance under the ...... nd application of, a new test.
@en
Driving performance under the ...... nd application of, a new test.
@nl
prefLabel
Driving performance under the ...... nd application of, a new test.
@ast
Driving performance under the ...... nd application of, a new test.
@en
Driving performance under the ...... nd application of, a new test.
@nl
P2860
P1476
Driving performance under the ...... nd application of, a new test.
@en
P2093
O'Hanlon JF
P2860
P304
P356
10.1111/J.1365-2125.1984.TB02590.X
P407
P478
18 Suppl 1
P577
1984-01-01T00:00:00Z